Evaluating the potential for immune escape: how likely is an antibody to protect against a specific SARS-CoV-2 variant?
Author(s): Allyson Sterling1, Erica Lannan2, Sandra Porter3
1. Regis University 2. Prairie State College 3. Digital World Biology
134 total view(s), 167 download(s)
Summary:
Commercial antibodies to the SARS-CoV-2 spike protein have been successfully used to treat people with COVID-19. Unfortunately, as the SARS-CoV-2 virus evolves, new variants have appeared that can escape some of these antibodies. In fact, many…
Contents:
Instructions.docx(DOCX | 4 MB)
Worksheet ANSWER KEY.docx(DOCX | 2 MB)
- https://NextStrain.org
- National Center for Biotechnology Information
- SARS CoV 2 variants vs Antibodies - YouTube
- iCn3D: Web-based 3D Structure Viewer
- SAbDab: The Structural Antibody Database
SARS-CoV-2 Abs vs Variants Feb2022.pptx(PPTX)
- License terms
Comments
There are no comments on this resource.